Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lorenzo Antonio Ramirez, Tatiana Arango & Jean Boyer. (2013) Therapeutic and prophylactic DNA vaccines for HIV-1. Expert Opinion on Biological Therapy 13:4, pages 563-573.
Read now
Read now
Articles from other publishers (5)
Aitana Almodóvar-Payá, Mónica Villarreal-Salazar, Noemí de Luna, Gisela Nogales-Gadea, Alberto Real-Martínez, Antoni L. Andreu, Miguel Angel Martín, Joaquin Arenas, Alejandro Lucia, John Vissing, Thomas Krag & Tomàs Pinós. (2020) Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models. International Journal of Molecular Sciences 21:24, pages 9621.
Crossref
Crossref
Franco Pissani, Bianca Schulte, Michael A. Eller, Bruce T. Schultz, Silvia Ratto-Kim, Mary Marovich, Prasert Thongcharoen, Somchai Sriplienchan, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Stefan Esser, Galit Alter, Merlin L. Robb, Jerome H. Kim, Nelson L. Michael & Hendrik Streeck. (2018) Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans. Journal of Virology 92:23.
Crossref
Crossref
Byoung-Jun Kim, Bo-Ram Kim, Yoon-Hoh Kook & Bum-Joon Kim. (2018) Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine. Frontiers in Immunology 9.
Crossref
Crossref
Nadia Chanzu & Beatrice Ondondo. (2014) Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy. Frontiers in Immunology 5.
Crossref
Crossref
Anton V. Borovjagin, Jorge G. Gomez-Gutierrez, Haval Shirwan & Qiana L. Matthews. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development
203
271
.